Industry / China
EU Cautious Over Imported APIs
October 2007 | Industry NewsCalls within the European Union (EU) to tighten safety regulations for imported of active pharmaceutical ingredients (APIs) have intensified on the back of a number of scares over Chinese-produced goods. In the US, there have been a number of product recalls in recent months, ranging from food items to toys, damaging the 'Made in China'
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
